BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China
· Delayed Price · Currency is CNY 40.25
-0.67 (-1.64%)
At close: Mar 9, 2026
SHA:688166 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 189.17 | 202.47 | 239.62 | 243.95 | Upgrade
|
| Depreciation & Amortization | - | 109.94 | 78.06 | 50.47 | 41.5 | Upgrade
|
| Other Amortization | - | 10.66 | 10.54 | 11.09 | 10.83 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.01 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 8.39 | 1.75 | 1.57 | 0.26 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 11.97 | 12.41 | -3 | -10.02 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 11.57 | 0.9 | -2.23 | 10.11 | Upgrade
|
| Other Operating Activities | - | 20.46 | 37.19 | -1.08 | 8.27 | Upgrade
|
| Change in Accounts Receivable | - | -149.93 | -17.85 | 4.96 | -241.94 | Upgrade
|
| Change in Inventory | - | -35.55 | -85.77 | -94.94 | -6.25 | Upgrade
|
| Change in Accounts Payable | - | 84.4 | -23.61 | 130.2 | 116.92 | Upgrade
|
| Change in Other Net Operating Assets | - | 15.75 | -2.96 | -21.31 | 4.16 | Upgrade
|
| Operating Cash Flow | - | 245.56 | 194.77 | 311.26 | 176.08 | Upgrade
|
| Operating Cash Flow Growth | - | 26.08% | -37.43% | 76.78% | 13.28% | Upgrade
|
| Capital Expenditures | - | -257.2 | -403.76 | -726.73 | -909.66 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.3 | 0.48 | 0.38 | 0.05 | Upgrade
|
| Cash Acquisitions | - | - | - | 0.01 | -7.5 | Upgrade
|
| Investment in Securities | - | -228.61 | -64.24 | -153.38 | 8.64 | Upgrade
|
| Other Investing Activities | - | 45.37 | 31.26 | 18.24 | 18.64 | Upgrade
|
| Investing Cash Flow | - | -440.14 | -439.85 | -871.58 | -889.84 | Upgrade
|
| Long-Term Debt Issued | - | 823.08 | 678.23 | 1,646 | 882.2 | Upgrade
|
| Total Debt Issued | - | 823.08 | 678.23 | 1,646 | 882.2 | Upgrade
|
| Long-Term Debt Repaid | - | -804.81 | -569.61 | -474.12 | -210.88 | Upgrade
|
| Total Debt Repaid | - | -804.81 | -569.61 | -474.12 | -210.88 | Upgrade
|
| Net Debt Issued (Repaid) | - | 18.27 | 108.62 | 1,172 | 671.32 | Upgrade
|
| Issuance of Common Stock | - | - | - | 219.81 | - | Upgrade
|
| Repurchase of Common Stock | - | -10.01 | - | - | - | Upgrade
|
| Common Dividends Paid | - | -135.73 | -115.01 | -100.1 | -54.3 | Upgrade
|
| Other Financing Activities | - | 103 | 68 | 73 | 86.7 | Upgrade
|
| Financing Cash Flow | - | -24.47 | 61.61 | 1,365 | 703.72 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 2.12 | 2.78 | 14.15 | 3.72 | Upgrade
|
| Net Cash Flow | - | -216.94 | -180.69 | 818.52 | -6.32 | Upgrade
|
| Free Cash Flow | - | -11.64 | -209 | -415.47 | -733.59 | Upgrade
|
| Free Cash Flow Margin | - | -0.91% | -17.72% | -40.84% | -69.71% | Upgrade
|
| Free Cash Flow Per Share | - | -0.03 | -0.49 | -1.01 | -1.80 | Upgrade
|
| Cash Income Tax Paid | - | 25.46 | 29.42 | -17.03 | -7.18 | Upgrade
|
| Levered Free Cash Flow | - | -65.73 | -316.64 | -515.42 | -785.87 | Upgrade
|
| Unlevered Free Cash Flow | - | -32.96 | -288.87 | -500.6 | -779.81 | Upgrade
|
| Change in Working Capital | - | -116.59 | -148.54 | 14.83 | -128.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.